News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

McKesson Corporation Said Near Deal for Haniel's Stake in Celesio AG



10/23/2013 7:26:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

McKesson Corp. (MCK) is near an agreement to buy a majority stake in German drug wholesaler Celesio AG (CLS1) to bundle its purchasing and gain global influence, said two people with knowledge of the discussions. Franz Haniel & Cie GmbH, the family-owned company that owns the 50.01 percent stake, and McKesson are trying to reach agreement in time to announce it with McKesson’s quarterly earnings tomorrow, said the people, who asked not to be identified because the talks are private. San Francisco-based McKesson then would be required under German law to make an offer to buy the remaining Celesio shares, the people said.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at Reuters


comments powered by Disqus
Bloomberg
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES